COX-2-Inhibitor - A New Class of Analgesic and Anti-inflammatory Drugs
Year: 2002
Type: article
Abstract: After mo re th an a century o f use. pharmaco lo gists felt th at th ey had discovered th e mechani s m of ac ti o n o f no n steroidal anti-inflammatory drugs (NSAIDs) whe n th eir inhibitory action o n the prod ucti o n of prostaglandins was described . This ac tion was located at th e inhibiti o n o f the enzyme respo nsi bl e fo r the conve rs io n o f arachido ni c acid to prostaglandins, namely cyclooxygenase. Recentl y, it has been recogni zed th at mo re than one isoform o f th e enzyme e xi sts . The two forms o f cyclooxygenase described are widely diffe rent in their locati o n, acti vity, and ro le. es peciall y because the COX-I isoenzyme seems to be mainly a constituti ve e nzyme, whe reas the COX-2 isoenzyme is inducibl e. This separati o n o f acti vit y ap pears to be correlated with th e separati o n o f fun cti o n o f the vari o us prostaglandins. whe reas the constitutive form is associated with ph ys iologic fun cti ons and the induci bl e fo rm with infl ammatory responses. Recent advances have inclu ded the de velopment of drugs with a hi gh specifi city towards th e inducibl e e nzyme (COX-2) to focu s on the anti-infl ammatory ac ti o ns, because many o f the unwant ed side e ffects o f NSAIDs have been associated with inhibiti on o f the constituti ve isoform (CO X-I ). The present review di scusses the developme nt of COX-2 inhibito rs and th eir introducti o n in the mark e t as useful drugs.
Authors: Mohammad Amir, Shikha Kumar
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2400700404
